Schaerf Raymond H M, Najibi Sasan, Conrad John
Providence St Joseph Medical Center Lead Management Center, Burbank, CA.
J Atr Fibrillation. 2016 Oct 31;9(3):1455. doi: 10.4022/jafib.1455. eCollection 2016 Oct-Nov.
This case series reports our early experience with a minimally invasive percutaneous method of safely removing large vegetations during lead extraction in septic cardiac implantable electronic devices (CIED). Debate exists concerning the management of vegetations involving these devices. Lead extraction is mandated for infections, but vegetations may embolize, causing complications. Surgical debridement is recommended; alternatives include cardiopulmonary bypass, minimally invasive thoracotomy, or transatrial approaches. The AngioVac device allows percutaneous right heart bypass and suction removal of vegetations under echocardiographic and fluoroscopic guidance. This case series describes our first 20 patients, all critically ill with persistent sepsis and vegetations despite long-term antibiotics. This series includes patients who would not have been eligible for alternative procedures due to contraindications and highlights the potential role of this new technology.
本病例系列报告了我们在感染性心脏植入式电子设备(CIED)导线拔除过程中,采用微创经皮方法安全移除大型赘生物的早期经验。对于涉及这些设备的赘生物的处理存在争议。感染时必须进行导线拔除,但赘生物可能会发生栓塞,引发并发症。建议进行外科清创术;其他方法包括体外循环、微创开胸手术或经心房入路。AngioVac设备可在超声心动图和荧光透视引导下经皮进行右心旁路和赘生物抽吸清除。本病例系列描述了我们的前20例患者,他们均病情危重,尽管长期使用抗生素仍持续存在败血症和赘生物。该系列包括因禁忌症而不符合其他手术条件的患者,并突出了这项新技术的潜在作用。